You are here
- Home
- Total number of clinical trials
A Phase I, open label, multicentre study to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of the mTor Kinase Inhibitor AZD2014 administered orally to patients with advanced solid malignancies.
- Disease
- solid tumour
- Drug Name
- AZD2014
- Generic Name
- AZD2014
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Jan 18, 1971
- Study Name
- D2270C00001
- Study Id
- D2270C00001
- ClinicalTrials.gov ID
- NCT01026402
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
